Associates to be based at 22,000 square foot space at Manchester’s
MANCHESTER, N.H.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/AmeriHealthCaritas?src=hash” target=”_blank”gt;#AmeriHealthCaritaslt;/agt;–AmeriHealth Caritas New Hampshire, a managed care organization that will
begin serving New Hampshire Medicaid enrollees in September 2019 and
part of the AmeriHealth
Caritas Family of Companies, announced that it has executed a lease
for its headquarters at 25 Sundial Avenue in Manchester.
The space, within the Sundial
Center, will be the home base for AmeriHealth Caritas New
Hampshire’s associates, including its senior leadership team, medical
affairs, finance, and provider network management teams. The Sundial
Center contains an on-site daycare and café.
AmeriHealth Caritas New Hampshire has begun work to plan the 22,000
square foot space. Some associates are expected to begin working in the
space in June, with full occupancy expected in September.
“AmeriHealth Caritas Family of Companies spent a number of months
looking for a space that met our size, layout, and infrastructure needs,
while also being in a convenient location for our New Hampshire
workforce,” said AmeriHealth Caritas New Hampshire Market President
Scott Westover. “Sundial Center is a great place for us to set up our
home in the Granite State.”
About AmeriHealth Caritas New Hampshire
AmeriHealth Caritas New Hampshire is a managed care organization that
will begin serving enrollees in New Hampshire’s Medicaid Care Management
program beginning in September 2019. AmeriHealth Caritas New Hampshire
will help the state’s Medicaid population get care, stay well, and build
healthy communities by addressing the acute and broader social factors
that drive health outcomes.
About AmeriHealth Caritas Family of Companies
AmeriHealth Caritas is one of the nation’s leaders in health care
solutions for those most in need. Operating in 11 states and the
District of Columbia, AmeriHealth Caritas serves more than 5 million
Medicaid, Medicare, and Children’s Health Insurance Program (CHIP)
members through its integrated managed care products, pharmaceutical
benefit management and specialty pharmacy services, and behavioral
health services. Headquartered in Philadelphia, AmeriHealth Caritas is a
mission-driven organization with more than 35 years of experience
serving low-income and chronically ill populations. AmeriHealth Caritas
is part of the Independence Health Group in partnership with Blue Cross
Blue Shield of Michigan. For more information, visit www.amerihealthcaritas.com.
Nextleaf Solutions Provides Commercial Update
Vancouver, British Columbia–(Newsfile Corp. – July 6, 2020) – Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf“, “OILS“, or the “Company“), Canada’s most innovative cannabis extractor, is pleased to provide the following commercial update:
Bulk THC Distillate Supply Deal
Nextleaf Labs Ltd. (“Nextleaf Labs“), a Health Canada licensed standard processor of which the acquisition by OILS is pending, has entered into a bulk supply agreement with a B.C.-based multi-licensed cannabis producer focused on the distribution of adult-use cannabis products through provincial markets. Pursuant to the agreement, Nextleaf Labs has agreed to supply 50 kilograms of THC distillate to the purchaser.
“We are very pleased to be working with a team with tremendous depth of experience distributing cannabis products through provincial adult-use channels,” said Charles Ackerman, CFO. “As we continue to grow our revenue, we believe our lean overhead structure and purposeful business model, which hasn’t deviated since our Company’s founding, will allow OILS to achieve and maintain profitability in the near team, and as our industry continues to commoditize. We believe our investment in innovation will help us to ensure the long-term sustainability of our business and provide a robust platform to scale globally from our base in Canada,” continued Ackerman.
This agreement represents an important milestone for the Company, allowing OILS to continue the commercialization of its intellectual property (“IP“) portfolio through the production of cannabis oils and concentrates by Nextleaf Labs. OILS owns a portfolio of over 35 issued patents and 65 pending patents for the extraction, distillation, and formulation of cannabinoids.
Concurrent with commercialization of the Company’s IP through distilled cannabis oil production, Nextleaf has made several key hires in operations and quality assurance roles to support increased growth and fundamentals. The Company has been able to recruit highly-trained staff with existing cannabis production and manufacturing experience.
“The recent downsizing by a number of Canada’s largest cannabis producers has allowed OILS to add some very experienced operators to our team, who I expect will play a major role in our growth as a company over the next few years,” said Paul Pedersen, CEO of Nextleaf Solutions. “With an the abundant supply of dried cannabis biomass, Nextleaf Labs is developing a competitive advantage by utilizing more efficient proprietary technology to transform otherwise unsellable biomass into high-purity THC and CBD oils at a lower cost per milligram compared to processors running less efficient off-the-shelf extraction technology,” continued Pedersen.
The Company is focused on reaching full utilization of over half a tonne of biomass processing per day at its Metro Vancouver cannabis oil refinery in 2020. Nextleaf Labs is processing biomass under the Cannabis Extraction Agreement announced on April 2, 2020 with a 10-acre greenhouse cannabis grower. Nextleaf Labs expects to continue scaling its operations through toll processing and the supply of bulk cannabis concentrates. The industry has seen increased demand for economical extraction and distillation due to the legalization of cannabis 2.0 derivative products, and an over supply of dried cannabis biomass that has a shorter shelf life compared to cannabis oils.
Employee Equity Participation Plan
The Company announced today that it has issued shares under its Employee Equity Participation Plan (the “Plan“) implemented on April 1st in response to the COVID-19 pandemic to align the efforts and compensation of non-executive employees with the Company’s long-term business strategy.
The Plan is fully voluntary and permits non-executive employees to receive common shares in the capital of the Company in lieu of a portion of an employee’s cash compensation. The Plan allows the Company to reduce the cash component of employee compensation and further align incentives across the team.
Under the Plan for the month of June, Nextleaf has issued an aggregate of 68,126 common shares at a price of $0.285 per share.
OILS is Canada’s most innovative cannabis extractor, developing technology for extracting and distilling THC and CBD oils. Nextleaf’s industrial-scale extraction plant in Metro Vancouver has a design capacity to process 600 kg per day of dried cannabis biomass into distilled oils. The Company owns a portfolio of over 35 issued patents and 65 pending patents for the extraction and distillation of cannabinoids. Nextleaf Solutions commercializes its patent portfolio through IP licensing, and the wholesale of THC and CBD oils through Nextleaf Labs, a Health Canada licensed standard processor.
Nextleaf Solutions trades as OILS on the Canadian Securities Exchange, OILFF on the OTCQB Market in the United States, and L0MA on the Frankfurt Stock Exchange.
For further information, please contact:
604-283-2301 (ext. 219)
On behalf of the Board of Directors of the Company,
Paul Pedersen, CEO
Certain statements contained in this press release constitute “forward-looking statements”. All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the Company’s ability to capitalize on its IP portfolio, expectations regarding lower costs resulting from utilization of the Company’s technology, changes in the global market for cannabinoid-based products, the potential for shareholder value creation through the formalization and protection of IP, the Company’s future profitability and expected revenue growth, the long-term sustainability of the Company’s business model, the ability to scale the Company’s business globally, the Company’s strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”, “project”, “seek”, “should” or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company’s expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company’s MD&A for the most recent fiscal period. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law. The CSE has not reviewed, approved or disapproved the contents of this press release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/59174
Sun Kissed Industries Inc.’s Numuni Subsidiary Launches Full BETA Sales Affiliate Program with a Highly Accomplished List of Initial Sales Affiliates
New York, New York–(Newsfile Corp. – July 6, 2020) – Sun Kissed Industries Inc. (OTC Pink: SKDI) (“Sun Kissed”, “SKDI”), an emerging leader in the development and sale of CBD consumables, digital content management, and online ad monetization technology,”), is pleased to provide a key and very exciting update for its current and prospective investors, as the Company moves forward with the full BETA launch of the Numuni Sales Affiliate Program.
Sun Kissed Industries Inc. Logo
To view an enhanced version of this logo, please visit:
Numuni Inc. Logo
To view an enhanced version of this logo, please visit:
Numuni Inc. (“Numuni”), a monetization platform developed for digital media publishers, software providers, and online games, has already acquired nearly 100 affiliates and just began BETA testing their sales program on July 1st, 2020.
Numuni will develop all sales training materials and additional technical features based on the feedback of their newly acquired BETA Sales Affiliates and plans to finish the development of its pre-existing software infrastructure during this time. BETA Sales Affiliates will have the ability to earn a 5% lifetime commission of the earnings generated by any website publishers they refer to Numuni. This will provide Numuni with significant traction and revenue-generating capabilities immediately upon the full pending public launch of its robust platform.
Robert Reynolds, the founder and CEO of Numuni stated, “We are extremely thrilled to collaborate with our highly influential and experienced BETA Affiliates in building the foundation of our sales acquisition strategy over the next 45-60 days. Their feedback will be 1 of the initial key essential steps in helping us hit the ground running when our software is fully launched to market.”
By utilizing the same sales acquisition model in his prior endeavor, CPAlead, Robert was able to acquire over +150,000 website publishers, making CPAlead the 40th fastest-growing private company in the USA.
Similarly, Numuni will now be extremely favorably positioned to rapidly scale up its sales operations, by using their affiliate marketing team, and without relying on the high overhead cost of expensive marketing campaigns.
“The digital content monetization market is ripe for disruption again, even more so this time around. And our truly groundbreaking sector disruptive technology is going to be an extreme game-changer,” Mr. Reynolds sums up in concise terms.
Digital publishers are increasingly considering truly effective alternative monetization methods due to the decline of traditional ad revenues and rising public opposition against users’ private data being sold. Numuni plans to capitalize on this growing market trend, having already received pre-commitments from multiple Top-50 trafficked websites, and will utilize its robust and groundbreaking Sales Affiliate Program to rapidly acquire many more worthy & relevant high trafficked websites over the balance of this year and beyond.
About Sun Kissed Industries, Inc.:
Sun Kissed Industries Inc. (OTC Pink: SKDI) is an emerging leader in the development and sale of CBD consumables, digital content management, and online ad monetization technology. The Company is pursuing meaningful acquisitions as part of an aggressive M&A strategy designed to position Sun Kissed as a dominant player in well-defined, high-growth markets within rapidly expanding sectors.
About Numuni, Inc.:
Numuni is a technology platform that aims to disrupt the digital marketplace for paid content by making use of the vast amount of unused computing resources that personal computer desktops have. Numuni is positioned to truly transform the user experience of consuming digital content, increasing the content provider’s earnings as they deliver that experience, as well as leverage the GPU computing power as a commodity to increase efficiency and cost savings.
Hakuna is an award-winning CBD-products company, currently nominated for “Best Hemp-Derived CBD Product” by the California Cannabis Awards after winning the DOPE Magazine Best New Product award for Southern California in the non-cannabis/non-tech category in 2017. Hakuna was also recently awarded “Runner Up” at the Los Angeles Coffee & Donut Festival People’s Choice Coffee Awards for 2019. Hakuna generates significant revenues with a substantial distribution footprint, including over 110 established retail distribution partners across over 20 states in the domestic US market.
This press release may contain forward-looking statements, including information about management’s view of Sun Kissed Industries Inc.’s future expectations, plans and prospects. In particular, when used in the preceding discussion, the words “believes,” “expects,” “intends,” “plans,” “anticipates,” or “may,” and similar conditional expressions are intended to identify forward-looking statements. Any statements made in this news release other than those of historical fact, about an action, event, or development, are forward-looking statements. These statements involve known and unknown risks, uncertainties, and other factors, which may cause the results of Sun Kissed, its subsidiaries and concepts to be materially different than those expressed or implied in such statements. Unknown or unpredictable factors also could have material adverse effects on Sun Kissed’s future results. The forward-looking statements included in this press release are made only as of the date hereof. Sun Kissed cannot guarantee future results, levels of activity, performance, or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, Sun Kissed undertakes no obligation to update these statements after the date of this release, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by Sun Kissed.
SOURCE: Sun Kissed Industries Inc.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/59166
IGNITE Provides an Update on the Filing of Its Q1 Financial Statements and MD&A
VAUGHAN, Ontario, July 06, 2020 (GLOBE NEWSWIRE) — IGNITE International Brands, Ltd. (CSE:BILZ, OTCQX: BILZF) (“IGNITE” or the “Company”), a global consumer packaged goods brand, announces that, further to its news release dated May 29, 2020 (“Initial Press Release”), the Company is expected to file its interim financial statements for the period ended March 31, 2020, interim MD&A for the same period and accompanying certificates (collectively, the “Interim Filings”) by July 15, 2020.
The following is a list of the Company’s material business developments since the Initial Press Release:On June 9, 2020, the Company announced that it has hired a new President (Lester Lee), replacing its prior acting President, Curtis Heffernan, and completed a private placement of convertible debentures totaling CA$5 million. Details were disclosed in a news release issued on June 9, 2020.
On June 15, 2020, the Company announced that it has closed the previously announced acquisition of Ignite Distribution Inc. Details of the acquisition and the consideration payable were disclosed in a news release issued on June 15, 2020.
On June 24, 2020, the Company announced that it has entered into an exclusivity agreement with Namaste’s CannMart to distribute certain of its products in Ontario and Alberta. Details were disclosed in a news release issued on June 24, 2020.ABOUT IGNITEIGNITE is a global consumer brand, operating in the premium product segment of the market. Founded by Dan Bilzerian, the Company’s ‘quality-first’ approach is fundamental to the brand and its products. Originally operating in the cannabis and hemp-derived cannabidiol (CBD) wellness space, IGNITE was able to establish its brand awareness. IGNITE product categories now include a full line of CBD oil tinctures, CBD topicals, CBD pet products and CBD vape devices, produced by various partners and sold through select distributors, brick and mortar retailers, and online through the Company’s website, ignite.co. The IGNITE THC product line, which was launched subsequent to the CBD product line, incorporates quality, locally sourced, cannabis products.Since the launching of its THC and CBD products, the Company has expanded into the beverage space, launching a full line of functional performance enhancing drinks. The IGNITE beverage line currently consists of PH-alkaline balanced water, a line of premium performance drinks, named Z-RO as well as a gluten-free, seven-time distilled vodka. IGNITE beverages will be distributed nationally within the United States and available to purchase on the IGNITE beverages website, IgniteBeverages.co.IGNITE is a socially responsible company and is committed to using its marketing and brand power as a positive catalyst for a healthy lifestyle. The IGNITE management team believes that socially responsible oriented actions have a positive impact on the Company, its employees and its shareholders.Shares of IGNITE are listed on the Canadian Securities Exchange (CSE) under the symbol “BILZ” and quoted in the United States on the OTCQX under the symbol “BILZF”.Further information on IGNITE can be found on the Company’s website at ignite.coFor further information, please contact:
Linda K. Menzel, General Counsel
Email: email@example.comCautionary Statement Regarding Forward-Looking InformationThis news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to IGNITE, its ability to file the Interim Filings by July 15, 2020. Forward-looking statements are necessarily based upon several estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; the effects and impacts of the coronavirus disease (COVID-19) pandemic, the extent and duration of which are uncertain at this time on IGNITE’s business and general economic and business conditions and markets; the ability of IGNITE to give effect to its business plan; reliance on the “IGNITE” brand which may not prove to be as successful as contemplated; the ability to and risks associated with unlocking future licensing opportunities with the “IGNITE” brand, and the ability of IGNITE to capture significant market share. There can be no assurance that any of the forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether because of new information, future events or otherwise, except as required by law.
Cannabis3 weeks ago
Hemp, Inc. Rapidly Approaching $2 Million in Sales from Its Premium, High Quality Hemp Flower
Cannabis3 weeks ago
RETRANSMISSION: Hemp, Inc. Announces that Its First Ever Great American Hempathon is in Full Swing
Cannabis3 weeks ago
Banksy Collection Becomes Permanent Installation at Toronto’s Newest Cannabis Store
Cannabis3 weeks ago
Hemp, Inc. Announces Newly Enhanced King of Hemp Website
Cannabis4 weeks ago
From Solar to Hemp SinglePoint Continues to Drive Headlines and Increase Sales, Brand Recognition is Reaching New Heights as Articles and Interviews Publish
Cannabis3 weeks ago
Fountain Asset Corp. Announces Its Financial Results for the Quarter and Year Ended December 31, 2019
Cannabis3 weeks ago
XPhyto Therapeutics Corp.: Infectious Disease Oral Screening Test Advancement
Cannabis4 weeks ago
XPhyto’s Diagnostic Partners Receive BMBF Grant for Infectious Disease Screening Tests